Present your work to a global oncology community
Share research through oral and poster sessions and receive feedback from international peers.
3rd Edition · Singapore 2027· #CIOC2027
International Cancer & Immuno-Oncology Conference 2027
Innovations in Cancer Research and Treatment for Better Patient Outcomes
A three-day hybrid congress convening oncologists, immunologists, clinical researchers and policymakers to translate breakthroughs at the bench into outcomes at the bedside.
Dates
March 15–17, 20272027 · 3 days
Venue
SingaporeVillage Hotel Changi
Format
Hybrid EventIn-person & online
Hybrid Event
Venue
Village Hotel Changi, Singapore
Edition
3rd edition of the series
Countries
18 represented
Duration
3 days
About
About CIOC 2027
A three-day hybrid congress uniting global experts in oncology, cancer research, clinical practice, healthcare, industry and policy to accelerate advances across cancer prevention, diagnosis, treatment and patient care.
We are delighted to invite you to attend the 3rd Edition of International Cancer & Immuno-Oncology Conference (CIOC 2027), scheduled to be held from March 15–17, 2027, in Singapore and virtually. The conference will revolve around the theme “Innovations in Cancer Research and Treatment for Better Patient Outcomes,” highlighting the latest advancements and collaborative efforts in the global fight against cancer.
This Hybrid Conference will gather a diverse group of participants, including oncologists, cancer researchers, clinicians, healthcare professionals, scientists, industry experts, and students from across the globe. It serves as a multidisciplinary platform encouraging collaboration among professionals from universities, hospitals, research institutions, and healthcare industries.
CIOC 2027 will cover a wide range of topics closely related to oncology and immuno-oncology, including Cancer Biology, Cancer Genetics, Palliative Care, Precision Medicine, Immunotherapy, Radiation Oncology, Targeted Therapies, Cancer Prevention, Pediatric Oncology, and Translational Research. It will also emphasize emerging trends such as genomics, molecular diagnostics, artificial intelligence in oncology, and novel therapeutic approaches designed to enhance patient care and outcomes.
The conference will feature an extensive scientific program, including keynote speeches, plenary sessions, oral and poster presentations, workshops, symposiums, and panel discussions. These sessions will provide attendees with opportunities to present their research, gain insights from leading experts, and engage in meaningful discussions on recent developments and future directions in cancer science.
We look forward to welcoming you to Singapore and virtually for this inspiring and impactful event and to fostering meaningful collaborations in the fight against cancer.
30+
Countries represented to date
3
Days, hybrid format
Program · Tracks
Scientific sessions.
/ 01
Early Detection, Screening & Prevention
Early detection and prevention remain central to reducing cancer incidence, morbidity, and mortality. This session expl…
Track 01View session/ 02Cancer Epidemiology, Population Health, Access & Policy
This session addresses the distribution, determinants, and burden of cancer across populations and examines how healthc…
Track 02View session/ 03Cancer Pathology, Molecular Diagnostics & Biomarkers
Accurate diagnosis and molecular characterization are fundamental to modern cancer management. This session explores de…
Track 03View session/ 04Cancer Genetics, Genomics & Precision Oncology
Advances in genetics and genomics have transformed the understanding and treatment of cancer. This session focuses on h…
Track 04View session/ 05Cancer Biology & Tumor Microenvironment
Understanding the biological mechanisms that drive cancer initiation, progression, metastasis, and treatment resistance…
Track 05View session/ 06Breast Oncology
Breast oncology encompasses the prevention, diagnosis, molecular characterization, and multidisciplinary treatment of b…
Track 06View session/ 07Lung & Thoracic Oncology
Lung and thoracic malignancies remain major areas of cancer research and clinical innovation. This session covers advan…
Track 07View session/ 08Gastrointestinal Cancer
Gastrointestinal oncology covers a diverse group of malignancies affecting the digestive system and associated organs.…
Track 08View session/ 09Genitourinary Cancers
Genitourinary oncology encompasses cancers of the urinary system and male reproductive organs and continues to benefit…
Track 09View session/ 10Gynecologic Oncology
Gynecologic oncology focuses on cancers of the female reproductive system and integrates prevention, screening, surgery…
Track 10View session/ 11Hematologic Malignancies
Hematologic malignancies include a broad spectrum of cancers affecting blood, bone marrow, and lymphatic tissues. This…
Track 11View session/ 12Other Organ-Specific & Rare Cancers
This session provides dedicated coverage for important organ-specific and uncommon malignancies that may not fall withi…
Track 12View session/ 13Medical, Surgical & Radiation Oncology
Modern cancer treatment depends on coordinated use of systemic therapy, surgery, radiation, and multidisciplinary treat…
Track 13View session/ 14Cancer Immunology & Immuno-Oncology
Immuno-oncology has transformed cancer treatment by harnessing the immune system to recognize and eliminate malignant c…
Track 14View session/ 15Cancer Vaccines & Oncolytic Therapies
Cancer vaccines and oncolytic therapies represent rapidly developing approaches designed to stimulate or enhance antitu…
Track 15View session/ 16Cancer Drug Discovery, Targeted Therapy & ADCs
Advances in molecular understanding of cancer continue to drive the development of increasingly selective and effective…
Track 16View session/ 17Translational Oncology & Clinical Trials
Translational oncology connects laboratory discoveries with clinical applications and supports the development of new d…
Track 17View session/ 18AI, Imaging & Digital Oncology
Artificial intelligence, advanced imaging, digital technologies, and computational methods are increasingly influencing…
Track 18View session/ 19Emerging Technologies & Future Directions in Cancer Research
Rapid advances in experimental technologies are creating new opportunities to understand cancer biology and develop inn…
Track 19View session/ 20Pediatric & AYA Oncology
Cancers affecting children, adolescents, and young adults present distinct biological, therapeutic, and survivorship ch…
Track 20View session/ 21Geriatric Oncology & Cancer Aging
Cancer incidence rises with age, while older adults often present with unique biological, clinical, and treatment consi…
Track 21View session/ 22Palliative Care & Supportive Oncology
Supportive and palliative care are essential throughout the cancer journey and contribute significantly to symptom cont…
Track 22View session/ 23Cancer Survivorship & Long-Term Care
Improvements in cancer detection and treatment have increased the number of people living beyond a cancer diagnosis, cr…
Track 23View session/ 24Cancer Comorbidities & Multidisciplinary Care
Cancer frequently coexists with other acute and chronic conditions that can influence treatment decisions, toxicity, pr…
Track 24View sessionScientific Committee
Committee members.
Michael Thompson
University of Toronto, Canada
Thomas Jay Webster
Brown University, United States
Pietro Salvatori
Formerly, Humanitas San Pio X Hospital, Italy
Rajvir Dahiya
University of California San Francisco, United States
Jianhua Luo
University of Pittsburgh School of Medicine, United States
Atif A Ahmed
Seattle Children’s Hospital, United States
Sandrine Lacombe
University of Paris-Saclay, France
Yan Leyfman
NYP- Meyer Cancer Center, United States
Paulo Cesar De Morais
Catholic University of Brasilia, BrazilFeatured Speakers
2027 speakers.
Sergey Suchkov
N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Manmohan Agrawal
Pushpadi Hospital, India
Lanfranco De Gasperis
Independent Researcher, Canada
Eleni Petsalaki
University of Crete, Greece
Sheena Grace Diamante
University of the Philippines-Philippine General Hospital, Philippines
Hamza Saad
University of Central Missouri, United States
Can Küçük
Dokuz Eylul University, Turkey
Tyrone Clyde Saludez
University of the Philippines, Philippines
Jagmohan Lal Meena
ACTREC - Tata Memorial Centre, India
Xun Zeng
Zhejiang University, China
Ahora Chehri
Johann Wolfgang Goethe University Frankfurt am Main, Germany
Ratan Kumar Sarkar
Independent Researcher, IndiaSingapore · March 15–17, 2027
Until the opening plenary.
—
Days
—
Hours
—
Minutes
—
Seconds
Opens March 15–17, 2027
Village Hotel Changi, Singapore
Village Hotel Changi, Singapore
Important Dates
Key dates & deadlines.
16 Nov 2026First Round SubmissionNext
17 Nov 2026Early Bird RegistrationUpcoming
16 Dec 2026Mid Term RegistrationUpcoming
16 Dec 2026Second Round SubmissionUpcoming
1 Mar 2027Final Round SubmissionUpcoming
15 Mar 2027On Spot RegistrationUpcoming
Audience
Who should attend.
/ 01
Medical, Surgical & Radiation Oncologists
Review new trial evidence and compare treatment approaches across tumor types.
/ 02
Cancer Researchers & Tumor Biologists
Present your findings and discuss the mechanisms behind tumor growth, spread and resistance.
/ 03
Immunologists & Cell Therapy Scientists
Explore progress in checkpoint inhibitors, CAR-T, cancer vaccines and other immune-based therapies.
/ 04
Geneticists & Precision Medicine Specialists
Share work on cancer genomics, biomarkers and molecular profiling that guides personalized treatment.
/ 05
Pathologists, Radiologists & Diagnostic Specialists
Learn about new tools for screening, early detection, imaging and diagnosis.
/ 06
Organ-Specific Cancer Specialists
Join focused sessions on breast, lung, gastrointestinal, genitourinary, gynecologic, blood and rare cancers.
/ 07
Pediatric, AYA & Geriatric Oncology Specialists
Address the distinct treatment and follow-up needs of younger and older patients.
/ 08
Oncology Nurses, Palliative & Supportive Care Teams
Exchange practice on symptom control, patient care, rehabilitation and survivorship.
/ 09
Epidemiologists & Public Health Professionals
Discuss cancer prevention, screening programs, access to care and health policy.
/ 10
Pharmaceutical, Biotech & Clinical Trial Professionals
Connect on drug discovery, targeted therapies, antibody-drug conjugates and trial design.
/ 11
AI, Data & Digital Health Researchers
Present advances in artificial intelligence, imaging analysis and computational oncology.
/ 12
Students, Fellows & Early-Career Researchers
Present your first results, get expert feedback and build international connections.
Why attend
Why attend the International Cancer & Immuno-Oncology Conference.
Connect, learn, present, and collaborate with the global cancer research and oncology community.
Translate new evidence into treatment decisions
Engage with trial results, treatment advances and organ-specific developments across tumor types.
Advance immuno-oncology and cell-based therapy
Explore checkpoint inhibition, adoptive cell therapy, cancer vaccines and tumor immunology.
Connect genomic insight to clinical practice
Discuss cancer genetics, genomics, biomarkers and molecular profiling in diagnosis and therapy selection.
Compare multimodal treatment approaches
Examine surgical technique, radiotherapy advances and combined-modality strategies.
Address the needs of younger patients
Explore pediatric tumor biology, treatment tolerance, late effects and long-term follow-up.
Improve quality of life across the pathway
Discuss symptom control, supportive oncology, survivorship and end-of-life care.
Strengthen patient care and coordination
Learn from practice-based research across the treatment and survivorship pathway.
Apply computational methods to oncology
Discover developments in artificial intelligence, imaging analysis, real-world data and computational oncology.
Develop skills and professional connections
Present emerging work, receive expert feedback and build international academic networks.
Strengthen research visibility and collaboration
Support faculty, students and clinical teams in presenting their work and developing partnerships.
Connect cancer evidence with policy and practice
Engage with research on prevention, screening, epidemiology, access and care standards.
Connect with oncology decision-makers
Showcase technologies, therapeutics and services to researchers, clinicians and institutions.
Exchange knowledge across health systems
Compare treatment protocols, research priorities and care models with professionals from different countries.
Learn without submitting an abstract
Attend sessions, interact with speakers and stay updated on current cancer research and practice.
Past Editions
Previous editions.
Program
Conference schedule.
- Keynote · In-PersonLong-read sequencing reveals dynamic features of human malignanciesJianhua LuoUniversity of Pittsburgh School of Medicine, United States
- Keynote · In-PersonNanomedicine in over 45,000 patients and no cancerThomas Jay WebsterBrown University, United States
- Keynote · In-PersonPersonalized and precision medicine (PPM) through the view of bio design-inspired translational research: An option for clinical oncologists, caregivers and consumers to realize the potential of genomics-informed care to secure the human biosafetySergey SuchkovN.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
- Keynote · In-PersonTheranostic nanoparticles – radiation therapies combined protocolsSandrine LacombeUniversity of Paris-Saclay, France
- Keynote · In-PersonNext generation tissue proteomics in cancer researchAtif A AhmedSeattle Children’s Hospital, United States
- Oral · In-PersonPersonalized and precision medicine as a unique avenue to have the healthcare model renewed to secure national biosafety: To get cancer treated or cured by integrating multifaceted approaches focusing on immunooncology?Sergey SuchkovN.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
- Oral · In-PersonTumor resectability and pathologic response after neoadjuvant long-course chemoradiotherapy for locally advanced rectal cancer in a resource-limited settingSamrawit S HalakeKampala International University, Uganda
- Oral · In-PersonHorizon Spectra: A comprehensive cancer genomics tertiary platform for ultra-rapid analysisMohammed UddinGenomeArc Inc, Canada
- Keynote · VirtualPrecision oncology, genetic testing and gene therapyRajvir DahiyaUniversity of California San Francisco, United States
- Keynote · VirtualGraphene quantum dots: A new frontier for photodynamic therapyPaulo Cesar De MoraisCatholic University of Brasilia, Brazil
- Keynote · VirtualOxygen-enriched oleic matrix dressings (Novox®) in head and neck surgery: a scoping review and our experiencePietro SalvatoriFormerly, Humanitas San Pio X Hospital, Italy
- Oral · VirtualA novel mechanism of mitotic spindle formation in cancer cellsEleni PetsalakiUniversity of Crete, Greece
- Oral · VirtualHuman papillomavirus prevalence and genotype distribution among cervical cancer susceptible women of North Indian ethnicity in Gardasil vaccination era: Public health impactSaumya PandeyIndira IVF Hospital, India
- Oral · VirtualGenome-wide identification of SOX7 downstream targets and pathways in multiple myeloma through ChIP-Seq and RNA-SeqCan KüçükDokuz Eylul University, Turkey
- Oral · VirtualRehabilitation for cancer-related lymphedema: An evidence-based review of current interventions and clinical outcomesJagmohan Lal MeenaACTREC - Tata Memorial Centre, India
- Oral · VirtualSTAT proteins as regulators of epigenetic and epitranscriptomic landscapes in T helper cell differentiation in NSCLCKoustav SarkarSRM Institute of Science and Technology, India
- Keynote · VirtualNanoparticle-based chemiluminescent detection of an ovarian cancer biomarker – A clinically-relevant pilot studyMichael ThompsonUniversity of Toronto, Canada
- Keynote · VirtualEvolving concepts of breast cancer management and recent trendsManmohan AgrawalPushpadi Hospital, India
- Oral · VirtualInvestigating the role of mesenchymal stem cell exosomes programmed by the breast cancer microenvironment in the rearrangement of inflammatory pathways, phenotypic changes, and interaction with immune cells in a multicellular in vitro modelAhora ChehriJohann Wolfgang Goethe University Frankfurt am Main, Germany
- Oral · VirtualThe mathematical interpretation of breast cancer drugsRatan Kumar SarkarIndependent Researcher, India
Past Conference Reviews
Hear from delegates.
Testimonials
What past delegates say.
Thank you for a global scientifically stimulating enriching dynamic collaborative global platform to intellectually serve as expert moderator-chair and speaker (oral presentation) at this prestigious meeting.
"I'm very honored to have participated in the conference "Cancer Research 2025”. During this conference, I learned a great deal about various aspects of tumor treatment through communicating with all of the participants, and it also broadened my horizons. Thank you for giving me this opportunity."
I'd like to take this opportunity to thank you again for your organization. Well done. I really appreciated all the presentations.